Tumor
Conditions
Interventions
Malignant tumor patients group:NA
Co-resident group of tumor patients:NA
Sponsors
Hebei General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Experimental group: All cancer patients confirmed by pathologist after surgery were affected by the SARS-CoV-2. Control group: The co-living persons of the patients in the experimental group.
Exclusion criteria
Exclusion criteria: Experimental group: The cancer patients who were chosen in the experimental group were of the following characteristics:1)uninfected by the SARS-CoV-2;2)with serious primary diseases of liver, kidney, hematopoietic and nervous system;3)with congenital heart failure and arrhythmia;4)with acquired platelet dysfunction;5)with mental illness. Control group: The people in the control group were of the following characteristics:1)with malignant tumor;2)not infected with novel coronavirus;3)with serious primary diseases of liver, kidney, hematopoietic and nervous system;4) with congenital heart failure and arrhythmia;5) with acquired platelet dysfunction;6) with mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IL-6;Immunoglobulin;C-reactive protein;D-dimer;Generalized Anxiety Disorder 7-item;Patient Health Questionnaire-9;Fatigue Scale-14; | — |
Countries
People’s Republic of China
Contacts
Public ContactJia Yitao
Hebei General Hospital
Outcome results
None listed